Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Arthritis Rheum ; 43(6): 1233-43, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10857782

ABSTRACT

OBJECTIVE: To investigate the expression of human cartilage (HC) gp-39, a possible autoantigen in rheumatoid arthritis (RA), in peripheral blood and synovium, to characterize its cellular source, and to analyze correlations with clinical features. METHODS: The expression of HC gp-39 in synovium and peripheral blood mononuclear cells (PBMC) was assessed by immunohistochemistry and flow cytometry. Synthesis and secretion were investigated by both reverse transcription-polymerase chain reaction and enzyme-linked immunosorbent assay. RESULTS: PBMC expressing HC gp-39 were increased in RA patients compared with spondylarthropathy patients (P = 0.0029) and with healthy control subjects (P = 0.0013). HC gp-39+ cells were also slightly overrepresented in RA synovium (P = 0.01). In both blood and synovium, HC gp-39+ cells were identified as CD14dim,CD16+ monocytes, a phenotype which can differentiate from classic CD14++ monocytes by maturation in vitro. HC gp-39 messenger RNA was detected in RA synovium and PBMC, and PBMC secreted HC gp-39 in vitro. The number of HC gp-39+ PBMC correlated with serum levels of C-reactive protein (r = 0.39, P = 0.003) and HC gp-39 (r = 0.52, P = 0.014). HC gp-39 expression in RA synovial lining correlated with joint destruction (r = 0.77, P < 0.001). CONCLUSION: CD16+ monocytes, a cellular source of HC gp-39 in vivo, are overrepresented in both RA peripheral blood and synovial tissue. The presence of HC gp-39+ cells in RA synovium is correlated with the degree of joint destruction. These data support a role of these cells in the local autoimmune response that leads to chronic inflammation and joint destruction.


Subject(s)
Antigens, CD/metabolism , Arthritis, Rheumatoid/metabolism , Cartilage, Articular/metabolism , Glycoproteins/metabolism , Monocytes/metabolism , Synovial Membrane/metabolism , Adipokines , Adult , Aged , Antigens, CD/blood , Arthritis, Rheumatoid/pathology , Cartilage, Articular/pathology , Cell Differentiation , Cells, Cultured , Chitinase-3-Like Protein 1 , Female , Glycoproteins/blood , Humans , Lectins , Male , Middle Aged , Monocytes/physiology , Phenotype , Synovial Membrane/pathology
2.
Nucleic Acids Res ; 28(10): 2069-74, 2000 May 15.
Article in English | MEDLINE | ID: mdl-10773074

ABSTRACT

Expression of heterologous proteins in Dictyostelium discoideum presents unique research opportunities, such as the functional analysis of complex human glycoproteins after random mutagenesis. In one study, human chorionic gonadotropin (hCG) and human follicle stimulating hormone were expressed in Dictyostelium. During the course of these experiments, we also investigated the role of codon usage and of the DNA sequence upstream of the ATG start codon. The Dictyostelium genome has a higher AT content than the human, resulting in a different codon preference. The hCG-beta gene contains three clusters with infrequently used codons that were changed to codons that are preferred by Dictyostelium. The results reported here show that optimizing the first 5-17 codons of the hCG gene contributes to 4- to 5-fold increased expression levels, but that further optimization has no significant effect. These observations suggest that optimal codon usage contributes to ribosome stabilization, but does not play an important role during the elongation phase of translation. Furthermore, adapting the 5'-sequence of the hCG gene to the Dictyostelium 'Kozak'-like sequence increased expression levels approximately 1.5-fold. Thus, using both codon optimization and 'Kozak' adaptation, a 6- to 8-fold increase in expression levels could be obtained for hCG.


Subject(s)
Chorionic Gonadotropin, beta Subunit, Human/genetics , Dictyostelium/genetics , Follicle Stimulating Hormone/genetics , Amino Acid Sequence , Animals , Base Sequence , Chorionic Gonadotropin, beta Subunit, Human/biosynthesis , Codon/genetics , Enzyme-Linked Immunosorbent Assay , Follicle Stimulating Hormone/biosynthesis , Genetic Techniques , Humans , Molecular Sequence Data , Peptide Chain Elongation, Translational , Recombinant Proteins/biosynthesis , Ribosomes/metabolism
3.
Arthritis Rheum ; 42(7): 1497-507, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10403279

ABSTRACT

OBJECTIVE: To analyze the CD4+ T cell responses to the human cartilage antigen glycoprotein-39 (HCgp-39) in the context of rheumatoid arthritis (RA)-associated (DRalphabeta1*0401) and nonassociated (DRalphabeta1*0402) HLA class II molecules. METHODS: Large numbers of HCgp-39-specific T cell hybridomas were generated following immunization of HLA-DR4/human CD4 transgenic, murine major histocompatibility complex class II deficient mice with native HCgp-39. Fine epitope mapping of DRalphabeta1*0401-and DRalphabeta1*0402-restricted T cell hybridomas was performed using overlapping synthetic peptides. Antigen-specific cytokine production by lymph node T cells was evaluated after immunization with native antigen. Proliferative T cell responses of healthy human subjects were compared with the T cell responses of patients with active RA using HCgp-39 epitopes defined in HLA-DR4 transgenic mice. RESULTS: CD4+ T cells from DRalphabeta1*0401 and DRalphabeta1*0402 transgenic mice identified completely different immunodominant peptide epitopes of HCgp-39, and this was not explained by known DR4-binding motifs or direct peptide-binding studies. DRalphabeta1*0401-restricted, antigen-specific T cells produced significantly more interferon-gamma and tumor necrosis factor a in response to HCgp-39 than did T cells from DRalphabeta1*0402 transgenic mice. Finally, HCgp-39 peptides defined in DRalphabeta1*0401 transgenic mice stimulated T cells from HLA-DR4 positive human subjects and RA patients, but not T cells from HLA-DR4 negative individuals. CONCLUSION: T cell epitopes of HCgp-39 that were defined in HLA-DR4 transgenic mice stimulated T cells from human subjects carrying RA-associated HLA-DR4 alleles. HLA-DR4 molecules may influence the disease process in RA both by presentation of selected peptide epitopes and by promoting the production of proinflammatory cytokines in synovial joints.


Subject(s)
Arthritis, Rheumatoid/immunology , Cartilage/immunology , HLA-DR4 Antigen/immunology , T-Lymphocytes/immunology , Adipokines , Alleles , Animals , Autoantigens , Chitinase-3-Like Protein 1 , Cytokines/biosynthesis , Epitope Mapping , Epitopes, T-Lymphocyte/chemistry , Female , Glycoproteins/immunology , Humans , Immunodominant Epitopes/immunology , Lectins , Male , Mice , Mice, Transgenic
4.
Arthritis Rheum ; 40(6): 1115-25, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9182922

ABSTRACT

OBJECTIVE: To identify a cartilage-derived autoantigen that is relevant to the rheumatoid arthritis (RA) disease process. METHODS: A DR4 (DRB1*0401) peptide binding motif was used for the selection of potential self reactive peptides within human cartilage glycoprotein-39 (HC gp-39), a protein that is differentially expressed at the site of chronic inflammation. Synthetic peptides accommodating the motif were tested for binding the RA-associated DR4 (DRB1*0401) molecules. High-affinity binders were then tested for their capacity to stimulate peripheral blood mononuclear cell responses in RA patients or healthy donors. To assess the arthritogenic nature of native HC gp-39, the protein was injected into BALB/c mice. RESULTS: HC gp-39-derived motif-based peptides were selectively recognized by peripheral blood T cells from RA patients. Injection of the intact protein into BALB/c mice resulted in immunity to HC gp-39, which was found to be associated with the development of a chronic, relapsing arthritis. Moreover, inhalation of the protein led to tolerization of antigen-specific T cells and to suppression of HC gp-39-induced arthritis. CONCLUSION: These data indicate that HC gp-39 is a target of the immune response in RA. Consequently, HC gp-39 is a candidate for antigen-specific immunotherapy.


Subject(s)
Arthritis, Rheumatoid/immunology , Autoantigens/immunology , Glycoproteins/immunology , Adipokines , Adult , Aged , Aged, 80 and over , Animals , Arthritis, Experimental/immunology , Cartilage/immunology , Chitinase-3-Like Protein 1 , Clone Cells , Epitopes , Female , Humans , Immune Tolerance , Lectins , Male , Mice , Mice, Inbred BALB C , Middle Aged , Peptides/immunology , T-Lymphocytes/cytology , T-Lymphocytes/immunology
5.
J Autoimmun ; 10(6): 569-78, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9451596

ABSTRACT

The pathogenesis of joint destruction in rheumatoid arthritis remains ill-defined. Joint destruction is thought to be the result of tissue damage mediated by T cells. The mere presence of articular cartilage appears responsible for sustaining chronic synovitis and thereby forwards a role for cartilage-responsive T cells in RA. Taking advantage of the positive DRB1*0401 association with RA susceptibility, we reasoned that T-cell recognition of autoantigens in RA would be restricted by DRB1*0401-encoded molecules. A DR4 (B1*0401) peptide binding motif was used for the identification of putative T-cell epitopes within human aggrecan, a candidate autoantigen. Thirteen peptides were synthesized and tested for binding DRB1*0401 or 0404-encoded molecules. Selected binders were tested for induction of proliferative responses in peripheral blood mononuclear cells from donors carrying the DR4 or DR1 specificity. Both healthy and RA donors responded to human aggrecan-derived peptides, thereby identifying these sequences as T-cell epitopes. Interestingly, responses to aggrecan-derived epitopes were significantly decreased in RA patients compared to controls. This was not due to an overall hyporesponsiveness of RA patients since responses to a recall antigen or mitogen did not differ from controls. The data suggest that in RA, aggrecan-specific T cells may exist in a different stage of activation or may have left the periphery to home to the joint.


Subject(s)
Extracellular Matrix Proteins , HLA-DR Antigens/metabolism , Peptide Fragments/metabolism , Proteoglycans/metabolism , Adult , Aged , Aggrecans , Amino Acid Sequence , Arthritis, Rheumatoid/immunology , Arthritis, Rheumatoid/metabolism , Binding Sites , Epitopes, T-Lymphocyte/immunology , Epitopes, T-Lymphocyte/metabolism , Female , HLA-DRB1 Chains , Humans , Lectins, C-Type , Leukocytes, Mononuclear/immunology , Lymphocyte Activation/immunology , Male , Middle Aged , Molecular Sequence Data , Peptide Fragments/immunology , Protein Binding , Proteoglycans/immunology , T-Lymphocytes/immunology
6.
Biochem J ; 282 ( Pt 1): 115-21, 1992 Feb 15.
Article in English | MEDLINE | ID: mdl-1371666

ABSTRACT

The epidermal growth factor (EGF) receptor is down-regulated during early infection with adenovirus, and this has been attributed to accelerated internalization and degradation of the receptor in the absence of ligand (Carlin, Tollefson, Brady, Hoffman & Wold (1989) Cell 57, 135-144]. Using pulse-chase analysis, we show that loss of functional EGF receptors after infection of human KB and A431 cells with adenovirus type 5 is accompanied by accumulation of a receptor precursor that remains fully sensitive to endoglycosidase H, indicative of retention in the endoplasmic reticulum. A truncated receptor, normally secreted by A431 cells, also accumulates intracellularly as an endoglycosidase H-sensitive precursor. In no case is the block in intracellular transport of EGF receptors complete. We conclude that both stimulation of EGF receptor internalization and degradation and inhibition of intracellular transport of newly synthesized EGF receptors from the endoplasmic reticulum towards the cell surface contribute to EGF receptor down-regulation in adenovirus-infected cells.


Subject(s)
Adenoviruses, Human/genetics , Endoplasmic Reticulum/metabolism , ErbB Receptors/metabolism , Carcinoma, Squamous Cell , Cell Line, Transformed , Cell Membrane/metabolism , Down-Regulation , ErbB Receptors/biosynthesis , Histocompatibility Antigens Class I/biosynthesis , Humans , KB Cells , Kinetics , Oligosaccharides/metabolism , Phosphotyrosine , Receptors, Transferrin/biosynthesis , Time Factors , Tyrosine/analogs & derivatives , Tyrosine/analysis
7.
Biochem J ; 271(1): 215-21, 1990 Oct 01.
Article in English | MEDLINE | ID: mdl-2171499

ABSTRACT

Epidermal growth factor (EGF)-induced receptor dimerization may provide a mechanism for activation of the receptor protein tyrosine kinase and for initiation of post-receptor signalling pathways. We have examined whether second messengers and agents that modulate EGF receptor function act at the level of receptor dimerization. Both the Ca2+ ionophore ionomycin and the tumour promotor tetradecanoylphorbol acetate (TPA), added shortly before EGF, inhibit EGF receptor protein tyrosine kinase activity in intact cells. In permeabilized cells, elevation of Ca2+ similarly inhibits EGF receptor function. The inhibitory effect of Ca2+, unlike that of TPA, appears not to be dependent on protein kinase C activity. Neither ionomycin nor phorbol ester affects EGF-induced receptor dimerization, as shown by cross-linking and immunoblotting techniques, although the phosphotyrosine content of both monomeric and dimeric receptors is strongly decreased. Furthermore, we show that EGF receptor dimerization is not affected by increases in cyclic AMP or intracellular pH, nor by changes in transmembrane potential, medium osmolarity or the glycosylation state of the receptor. These result suggest that modulation of EGF receptor function occurs at a step other than receptor dimerization.


Subject(s)
ErbB Receptors/physiology , Second Messenger Systems , Animals , Calcium/pharmacology , Cell Line , Cell Membrane Permeability , Cross-Linking Reagents , Cyclic AMP/metabolism , Down-Regulation , Enzyme Activation/drug effects , Epidermal Growth Factor/pharmacology , ErbB Receptors/antagonists & inhibitors , ErbB Receptors/chemistry , Glycosylation/drug effects , Humans , Hydrogen-Ion Concentration , Immunoblotting , Ionomycin/pharmacology , Macromolecular Substances , Membrane Potentials , Mice , Neuraminidase/pharmacology , Phosphorylation , Protein Kinase C/metabolism , Protein-Tyrosine Kinases/antagonists & inhibitors , Protein-Tyrosine Kinases/metabolism , Saline Solution, Hypertonic/pharmacology , Signal Transduction/drug effects , Tetradecanoylphorbol Acetate/pharmacology
8.
Cell Regul ; 1(9): 615-20, 1990 Aug.
Article in English | MEDLINE | ID: mdl-1964091

ABSTRACT

The possible involvement of a stimulatory guanosine triphosphate (GTP)-binding (G) protein in epidermal growth factor (EGF)-induced phosphoinositide hydrolysis has been investigated in permeabilized NIH-3T3 cells expressing the human EGF receptor. The mitogenic phospholipid lysophosphatidate (LPA), a potent inducer of phosphoinositide hydrolysis, was used as a control stimulus. In intact cells, pertussis toxin partially inhibits the LPA-induced formation of inositol phosphates, but has no effect on the response to EGF. In cells permeabilized with streptolysin-O, guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S) dramatically increases the initial rate of inositol phosphate formation induced by LPA. In contrast, activation of phospholipase C (PLC) by EGF occurs in a GTP-independent manner. Guanine 5'-O-(2-thiodiphosphate) (GDP beta S) which keeps G proteins in their inactive state, blocks the stimulation by LPA and GTP gamma S, but fails to affect the EGF-induced response. Tyrosine-containing substrate peptides, when added to permeabilized cells, inhibit EGF-induced phosphoinositide hydrolysis without interfering with the response to LPA and GTP gamma S. These data suggest that the EGF receptor does not utilize an intermediary G protein to activate PLC and that receptor-mediated activation of effector systems can be inhibited by exogenous substrate peptides.


Subject(s)
Epidermal Growth Factor/pharmacology , GTP-Binding Proteins/metabolism , Phosphatidylinositols/metabolism , Angiotensins/metabolism , Animals , Cell Line , Cell Membrane Permeability , Enzyme Activation , ErbB Receptors/drug effects , ErbB Receptors/metabolism , Guanosine 5'-O-(3-Thiotriphosphate)/pharmacology , Guanosine Triphosphate/metabolism , Humans , Hydrolysis , Kinetics , Mice , Pertussis Toxin , Type C Phospholipases/metabolism , Virulence Factors, Bordetella/pharmacology
9.
Virology ; 172(2): 634-42, 1989 Oct.
Article in English | MEDLINE | ID: mdl-2800341

ABSTRACT

We have introduced insertion and deletion mutations in the cloned DNA binding protein (DBP) gene of adenovirus type 5. The mutated DBP genes were subsequently introduced in the viral genome by a combination of in vitro and in vivo methods. The resulting mutant viruses were tested for their viability in human 293 cells and an initial characterization of these viruses was performed. Viable mutants with insertions in the carboxyl-terminal portion of the gene could not be obtained. In contrast, a number of viable mutants were constructed that contained insertions or deletions in the amino-terminal half of DBP. Several of these, which covered the region between amino acid (aa) residues 39 and 81, were phenotypically wild type, implying that this segment is completely dispensable for DBP function. However, mutations altering the region encompassed by aa 2-38 were, at least, partially defective suggesting that this region is important for full activity of the protein.


Subject(s)
Adenoviruses, Human/genetics , DNA, Viral/genetics , DNA-Binding Proteins/genetics , Adenoviruses, Human/growth & development , Amino Acid Sequence , Base Sequence , Cell Line , DNA Mutational Analysis , HeLa Cells , Humans , Molecular Sequence Data , Plasmids , Restriction Mapping , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...